For: | Shamoun L, Landerholm K, Balboa Ramilo A, Andersson RE, Dimberg J, Wågsäter D. Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer. World J Gastroenterol 2021; 27(30): 5076-5087 [PMID: 34497436 DOI: 10.3748/wjg.v27.i30.5076] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i30/5076.htm |
Number | Citing Articles |
1 |
Changsen Yang, Tiangang Song, Yajie Mo, Peixuan Wu, Haokun Tian, Lequan Wen, Yun Gao. Association of CCL4 rs10491121 and rs1634507 gene polymorphisms with cancer susceptibility: trial sequential analysis and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1133055
|
2 |
Ran Chen, Li Ma, Chang Jiang, Shucai Zhang. Expression and potential role of CCL4 in CD8+T cells in NSCLC. Clinical and Translational Oncology 2022; 24(12): 2420 doi: 10.1007/s12094-022-02913-9
|
3 |
Imke Atreya, Markus F. Neurath. How the Tumor Micromilieu Modulates the Recruitment and Activation of Colorectal Cancer-Infiltrating Lymphocytes. Biomedicines 2022; 10(11): 2940 doi: 10.3390/biomedicines10112940
|
4 |
Xu Shi, Jun Yu, Chen Lu, Qian Luo, Caihong Xu, Jie Li, Wei Wang. Screening of the shared pathogenic genes of ulcerative colitis and colorectal cancer by integrated bioinformatics analysis. Journal of Cellular and Molecular Medicine 2024; 28(5) doi: 10.1111/jcmm.17878
|
5 |
Wanli Gong, Jiayi Zhou, Yaqi Hou, juan Zhang, Peifeng He, Qi Yu. The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin‐derived deteriorated tumors. Skin Research and Technology 2024; 30(7) doi: 10.1111/srt.13774
|